B. Payami, A. Zarrin, M. Hosseinzadeh, H. Haybar, and S. Khodamoradi, “Amiodarone can still be a drug of choice at emergency departments for pre-excited atrial fibrillation even in the face of guidelines prohibition ”, Iran Jour Emerg Med, vol. 10, no. 1, p. e8, May 2023.